Dinoprostone, Prostaglandin E2 vaginal suppositories
What is this medicine?
DINOPROSTONE (dye noe PROST one), also known as PROSTAGLANDIN E2 (pros tuh GLAN din E2) stimulates contractions of the uterus. It is sometimes used after a miscarriage. This medicine may also be used to treat a condition called benign hydatidiform mole.
How should I use this medicine?
This medicine is inserted into the vagina by a health-care professional in a hospital or clinic setting. Remain lying down for 10 minutes after it is inserted.
Talk to your pediatrician regarding the use of this medicine in children. Special care may be needed.
What side effects may I notice from receiving this medicine?
Side effects that you should report to your doctor or health care professional as soon as possible:
allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue
dizziness or fainting
fever of 100.4 degrees F (38 degrees C) or higher
unusual or foul-smelling vaginal discharge
unusual vaginal bleeding, pelvic pain, or cramping
Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):
mild increase in body temperature that goes away
What may interact with this medicine?
What if I miss a dose?
This does not apply.
Where should I keep my medicine?
This drug is given in a hospital or clinic and will not be stored at home.
What should I tell my health care provider before I take this medicine?
They need to know if you have any of the following conditions:
lung or breathing disease, like asthma
uterine rupture or scars
vaginal, uterine, or pelvic inflammation or infection
an unusual or allergic reaction to dinoprostone, prostaglandins, other medicines, foods, dyes, or preservatives
What should I watch for while using this medicine?
You will be closely monitored while you receive this medicine.
Contact your doctor or health care professional immediately if you get signs and symptoms of infection or other complications, such as pelvic or lower abdominal pain, an unpleasant vaginal discharge, fever, chills, or increase in vaginal bleeding several days after treatment.
September 30, 2017